Literature DB >> 14318702

PARTIAL THROMBOPLASTIN TIME TEST WITH KAOLIN. NORMAL RANGE AND MODIFICATIONS FOR THE DIAGNOSIS OF HAEMOPHILIA AND CHRISTMAS DISEASE.

M O MATCHETT, G I INGRAM.   

Abstract

The partial thromboplastin time test provides a convenient and sensitive screening procedure for deficiencies of thromboplastic factors, especially factors VIII and IX. The test is carried out after preincubating the plasma for 10 minutes with kaolin, and Inosithin is used as a platelet substitute. The ;normal range' of the test has been estimated in terms of the differences encountered between random normal plasmas tested in pairs, because individual patients are usually tested against single control subjects. A patient's partial thromboplastin time should be regarded as abnormal if it is more than six seconds longer than the control time. In the diagnosis of haemophilia, patients' plasmas with concentrations of factor VIII as low as about 20% might be regarded as being within the range of normal, if the selected control subject's factor VIII happened to lie near the lower end of the normal range. When mild haemophilia is suspected, discrimination may be improved by diluting both the patient's and the control plasmas 1 in 20 in haemophilic plasma. With the test modified in this way the clotting time is prolonged, though the range of differences among normal subjects is unaltered, and plasmas with factor VIII concentrations below about 30%, i.e., in undiluted plasma, would be unlikely to be regarded as normal. The partial thromboplastin time may be similarly modified as a screening test for factor IX deficiency.Some clinical examples are reported.

Entities:  

Keywords:  BLOOD COAGULATION TESTS; CHRISTMAS DISEASE; DIAGNOSIS; HEMOPHILIA; INDICATORS AND REAGENTS; KAOLIN; THROMBOPLASTIN

Mesh:

Substances:

Year:  1965        PMID: 14318702      PMCID: PMC472982          DOI: 10.1136/jcp.18.4.465

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  SCREENING FOR BLEEDING STATES--THE PARTIAL THROMBOPLASTIN TEST.

Authors:  A J QUICK; M GEPPERT
Journal:  Am J Clin Pathol       Date:  1963-11       Impact factor: 2.493

2.  A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma.

Authors:  R M HARDISTY; J C MACPHERSON
Journal:  Thromb Diath Haemorrh       Date:  1962-05-15

3.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

4.  The normal range of the prothrombin time estimated by Quick's method.

Authors:  G I INGRAM; P ARMITAGE
Journal:  J Clin Pathol       Date:  1959-01       Impact factor: 3.411

5.  A rapid screening test for disorders of thromboplastin generation.

Authors:  N D HICKS; W R PITNEY
Journal:  Br J Haematol       Date:  1957-04       Impact factor: 6.998

6.  Initiation of blood coagulation by glass and related surfaces.

Authors:  J MARGOLIS
Journal:  J Physiol       Date:  1957-06-18       Impact factor: 5.182

7.  Diagnosis and control of the hemophilioid states with the partial thromboplastin time (PTT) test.

Authors:  N F RODMAN; E M BARROW; J B GRAHAM
Journal:  Am J Clin Pathol       Date:  1958-06       Impact factor: 2.493

8.  The thromboplastin generation test.

Authors:  R BIGGS; A S DOUGLAS
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

9.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

Authors:  R D LANGDELL; R H WAGNER; K M BRINKHOUS
Journal:  J Lab Clin Med       Date:  1953-04

10.  The partial thromboplastin time as a screening test for the detection of latent bleeders.

Authors:  S W NYE; J B GRAHAM; K M BRINKHOUS
Journal:  Am J Med Sci       Date:  1962-03       Impact factor: 2.378

View more
  10 in total

1.  Simple screening tests for the diagnosis of isolated clotting factor defects. With special reference to 'contact factor' defects.

Authors:  G I Ingram; S F Knights; C L Arocha-Piñango; J P Shepperd; J L Pérez-Requejo; D K Mills
Journal:  J Clin Pathol       Date:  1975-07       Impact factor: 3.411

2.  An approach to the evaluation of hemostasis.

Authors:  S B Hunter; F S Royal; L D Green
Journal:  J Natl Med Assoc       Date:  1977-09       Impact factor: 1.798

3.  Metabolic and blood coagulation changes during intravenous fat infusions.

Authors:  D J Reid
Journal:  Ann R Coll Surg Engl       Date:  1968-05       Impact factor: 1.891

4.  Coagulation factors in chronic liver disease.

Authors:  G W Donaldson; S H Davies; A Darg; J Richmond
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

5.  The fibrinolytic enzyme system of the rat: the effect of aminonucleoside-induced nephrotic syndrome.

Authors:  N A Marsh
Journal:  Br J Exp Pathol       Date:  1969-02

6.  Determinants of the thrombogenic potential of multiwalled carbon nanotubes.

Authors:  Andrew R Burke; Ravi N Singh; David L Carroll; John D Owen; Nancy D Kock; Ralph D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Biomaterials       Date:  2011-06-12       Impact factor: 12.479

7.  Partial thromboplastin time test with kaolin: diagnosis of haemophilia and Christmas disease without natural reference plasmas.

Authors:  S F Knights; G I Ingram
Journal:  J Clin Pathol       Date:  1967-07       Impact factor: 3.411

8.  Diagnosis of haemophilia: use of an artificial factor-VIII-deficient human plasma system.

Authors:  E M Essien; G I Ingram
Journal:  J Clin Pathol       Date:  1967-07       Impact factor: 3.411

9.  An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice.

Authors:  Bilgimol Chumappumkal Joseph; Byron Y Miyazawa; Charles T Esmon; Mitchell J Cohen; Annette von Drygalski; Laurent O Mosnier
Journal:  Blood Adv       Date:  2022-02-08

10.  Characterization and pharmacological properties of a novel multifunctional Kunitz inhibitor from Erythrina velutina seeds.

Authors:  Richele J A Machado; Norberto K V Monteiro; Ludovico Migliolo; Osmar N Silva; Michele F S Pinto; Adeliana S Oliveira; Octávio L Franco; Sumika Kiyota; Marcelo P Bemquerer; Adriana F Uchoa; Ana H A Morais; Elizeu A Santos
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.